AP NEWS
Click to copy
Press release content from Business Wire. The AP news staff was not involved in its creation.
Click to copy
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Global Rheumatoid Arthritis Diagnostic Devices Market 2019-2023 | 6% CAGR Projection Over the Next Five Years | Technavio

July 26, 2019
Technavio has announced its latest market research report titled global rheumatoid arthritis diagnostic devices market 2019-2023. (Graphic: Business Wire)
Technavio has announced its latest market research report titled global rheumatoid arthritis diagnostic devices market 2019-2023. (Graphic: Business Wire)

LONDON--(BUSINESS WIRE)--Jul 26, 2019--

The global rheumatoid arthritis diagnostic devices market is expected to post a CAGR of close to 6% during the period 2019-2023, according to the latest market research report by Technavio.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190726005105/en/

Technavio has announced its latest market research report titled global rheumatoid arthritis diagnostic devices market 2019-2023. (Graphic: Business Wire)

A key factor driving the growth of the global rheumatoid arthritis diagnostic devices market size is the increasing number of rheumatoid arthritis cases. The number of autoimmune disorders, such as rheumatoid arthritis has increased at a significant rate across the world. These autoimmune diseases are most common in the older population as the prevalence of rheumatoid arthritis increases with age. This increasing prevalence has pushed various countries across the world to conduct awareness programs. Furthermore, government bodies and private organizations are providing insurance facility to patients with rheumatoid arthritis. Thus, the increasing number of rheumatoid arthritis cases will fuel the growth of the market during the forecast period.

As per Technavio, the growing focus on biomarkers and precision medicine will have a positive impact on the market and contribute to its growth significantly over the forecast period. This global rheumatoid arthritis diagnostic devices market 2019-2023 research report also analyzes other important trends and market drivers that will affect market growth over 2019-2023.

Global Rheumatoid Arthritis Diagnostic Devices Market: Growing Focus on Biomarkers and Precision Medicine

Biomarkers provide information about the disease activity, and predictive biomarkers help clinicians to assess the probability of treatment response. Biomarkers can help to predict the development of rheumatoid arthritis in patients and improve the diagnosis rate by improving the serological test analysis. Thus, the focus on the development of novel biomarkers has increased, which has led to the emergence of multi biomarkers disease activity test (MBDA), which can help in better monitoring of rheumatoid arthritis. Thus, the growing focus on biomarkers and precision medicine is expected to fuel the rheumatoid arthritis diagnostic devices market during the forecast period.

“Apart from the growing focus on biomarkers and precision medicine, other factors such as the increase in funding for and clinical studies on rheumatoid arthritis, and the rising number of business strategies will have a significant impact on the rheumatoid arthritis diagnostic devices market growth during the forecast period,” says a senior analyst at Technavio.

Global Rheumatoid Arthritis Diagnostic Devices Market: Segmentation Analysis

This market research report segments the global rheumatoid arthritis diagnostic devices market size by product (analyzers, and consumables), and geographic regions (North America, Europe, Asia, and ROW).

The North American region led the rheumatoid arthritis diagnostic devices market in 2018, followed by Europe, Asia, and ROW respectively. The rheumatoid arthritis diagnostic devices market report identifies factors such as the increasing number of people with rheumatoid arthritis, the rising number of new product launches, and the growing adoption of early diagnostic tests, to account for the market dominance of North America during the forecast period.

Looking for more information on this market?Request a free sample report

Technavio’s sample reports are free of charge and contain multiple sections of the report such as the market size and forecast, drivers, challenges, trends, and more.

Some of the key topics covered in the report include:

Market Landscape

Market Sizing

Five Forces Analysis

Market Segmentation

Geographical Segmentation

Market Drivers

Market Challenges

Market Trends

Vendor Landscape

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190726005105/en/

CONTACT: Technavio Research

Jesse Maida

Media & Marketing Executive

US: +1 844 364 1100

UK: +44 203 893 3200

www.technavio.com

KEYWORD:

INDUSTRY KEYWORD: RESEARCH MEDICAL DEVICES BIOTECHNOLOGY OTHER HEALTH HEALTH GENERAL HEALTH SCIENCE

SOURCE: Technavio Research

Copyright Business Wire 2019.

PUB: 07/26/2019 06:30 AM/DISC: 07/26/2019 06:30 AM

http://www.businesswire.com/news/home/20190726005105/en

All contents © copyright 2019 The Associated Press. All rights reserved.